Intellectual Property Law and Policy
� Volume 12
| Författare: | Hansen Hugh C. |
| Titel: | Intellectual Property Law and Policy � Volume 12 |
| Utgivningsår: | 2013 |
| Omfång: | 738 sid. |
| Förlag: | Hart |
| ISBN: | 9781849460576 |
| Produkttyp: | Inbunden |
| Typ av verk: | Samlingsverk |
| Ämnesord: | Immaterialrätt |
Pris: 1427 SEK exkl. moms 
|
 This is a new Annual volume in the series collecting the presentations and discussion from the Annual Fordham IP Conference. The contributions, by leading world experts, analyse the most pressing issues in copyright, trademark and patent law as seen from the perspectives of the USA, the EU, Asia and WIPO. This volume, in common with its predecessors, makes a valuable and lasting contribution to the discourse in IP law, as well as trade and competition law. The contents, while always informative, are also critical and questioning of new developments and policy concerns. Contents: Foreword v Acknowledgements vii List of Sponsors ix Welcoming & Opening Remarks xv I. IP Policy and The European Union 1 II. The Judiciary and IP Policy 15 Part A: Europe 15 Part B: United States 25 III. Corporations & IP: General Counsel Roundtable 35 IV. Patent Law 49 Part A: An Overview of U.S. Patent Law Developments 49 Part B: Patent Law Developments in Japan 65 Part C: Cross-Border Patent Infringement: A Comparative Analysis 77 Part D: Work Sharing: Patent Offices: IP5 Group (Consisting of USPTO, JPO, SIPO, 91 KIPO and EPO) Strategy for Work Sharing and Related Foundation Projects Part E: Obviousness/Inventive Step 113 Part F: Subject Matter: “Intangible” Patents—Business Methods, Software, “Soft” 135 Patents, Second Medical Uses Appendix A: Martin J. Adelman, “Lundbeck and Chemical Product Inventions” 161 Part G: The Interface Between Biotech & IP: When Does Discovery Become 173 an Invention? Donald Pfaff & Sandra Sherman, “A Scientist’s View of the Timing of 178 Applications for Patents” Part H: Injunctive Relief: A Comparative Analysis 193 Part I: A New “Fair Use” Doctrine for Patents? 209 Part J: Acquisition of Evidence & Expert Witnesses: Comparative Damages 217 Part K: Monetization of Patent and Other IP Rights 231 Appendix A: David S. Bloch, “Monetization of Patent and Other IP Rights: 247 An Introduction” Appendix B: James G. McEwen, “The Impact of Monetization of Patent 252 Rights on Patent Prosecution” V. Copyright Law 257 Part A: Infringement & Remedies (ISP Participation; Temporary Reproduction 257 (Cablevision case), Making Available Right, Data Privacy) Part B: Information Society Directive, Secondary Liability, DRM, Private Copy 287 Levies, & Copyright Territoriality Part C: Rethinking Exceptions and Limitations: To What Extent Is Re-evaluation 315 Warranted? Permitted Under Treaties? Realistic? What Effect, If Any, Will the Google Book Settlement Have on Present Norms for Exceptions and Limitations? Part D: Music Distribution, Collecting Societies; DG Comp CISAC Inquiry 347 Part E: Creativity and the Internet: Are We Building a Sustainable Ecosystem? 373 VI. Trademark Law 387 Part A: EU Trademark Law Developments 387 Dev Gangjee , Non-Conventional Trademarks: The Shape of Things to Come 396 Part B: Dilution Actions: Dying or Growth Industry? 413 Part C: Trademarks and the Internet: “Use,” E-Commerce, Ad Words, eBay, 429 UDRP, ICANN, and new Registrars Part D: Right of Publicity/Privacy: Comparative Developments 451 Part E: Industrial Designs, Fashion, Ornamental Patents 467 Appendix A: Harri Salmi, “Community Designs: Update on OHIM Procedural 485 Matters and Case Law in the Boards of Appeal and the Court of First Instance” Part F: Trademarks & Free Speech 491 Appendix A: Gordon Humphreys, “Freedom of Speech and Trademarks: 503 Gauging Public Sensitivities or Curtailing Civil Liberties?” VII. Trade Law 509 Part A: Multilateral and Bilateral Relations 509 Part B: Enforcement and Counterfeiting: IP’s Drug War: Can it Be Won? What is the 527 Enforcement Role for WIPO? ACTA: What is it and What Should Be its Role? Appendix A: Roya Ghafele, “Of War and Peace: Analyzing the Policy 551 Discourse on Intellectual Property” Part C: Trade Policy and IP Rights: The Road Ahead; Development Agenda 567 Part D: United States v. China in the WTO 587 VIII. Competition Law 605 Part A: United States and Antitrust; FTC Agenda; Patent Misuse & Antitrust 605 Part B: DG Comp Pharma Inquiry: The Implications for Innovation 623 David Rosenberg, “The DG Comp PHARMA Inquiry: A View from the 629 Research-based Industry” Appendix A: Rt. Hon. Sir Robin Jacob, “The European Commission 647 Pharma Sector Inquiry” Appendix B: Rt. Hon. Sir Robin Jacob, “Patents and Pharmaceuticals— 649 a Paper given on 29th November at the Presentation of the Directorate-General of Competition’s Preliminary Report of the Pharma-sector Inquiry” Part C: Policy Interplay Between IP Rights and Antitrust/Competition Law: How Do 657 We Get It Right? Part D: Standard Setting 673 Appendix A: Anselm Kamperman Sanders, “Standards Setting in the ICT 696 Industry—IP or Competition Law? A Comparative Perspective” Index 707 |